Skip Navigation



Carcinogenesis Advance Access published online on January 20, 2005

Carcinogenesis, doi:10.1093/carcin/bgi018
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/4/771    most recent
bgi018v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chang, X.
Right arrow Articles by Bjeldanes, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, X.
Right arrow Articles by Bjeldanes, L. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Oxford University Press
Received August 17, 2004
Revised December 6, 2004
Accepted January 8, 2005

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

3,3'-diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice

Xiaofei Chang 1, Janet C. Tou 1, Chibo Hong 1, Hyeon-A Kim 1, Jacques E. Riby 1, Gary L. Firestone 2, and Leonard F. Bjeldanes 1*

1 Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA 94720, USA
2 Department of Molecular Cell Biology, University of California, Berkeley, California 94720, USA

* To whom correspondence should be addressed.
Leonard F. Bjeldanes, E-mail: lfb{at}nature.berkeley.edu


   Abstract

Studies have linked the consumption of broccoli and other cruciferous vegetables to reduced risk of breast cancer. The phytochemical indole-3-carbinol (I3C), present in cruciferous vegetables, and its major acid-catalyzed reaction product 3,3'-diindolylmethane (DIM) have bioactivities relevant to the inhibition of carcinogenesis. In this study, the effect of DIM on angiogenesis and tumorigenesis in a rodent model were investigated. We found that DIM produced a concentration-dependent decrease in proliferation, migration, invasion, and capillary tube formation of cultured human umbilical vein endothelial cells (HUVECs). Consistent with its antiproliferative effect, which was significant at only 5 µM DIM, this indole caused a G1 cell cycle arrest in actively proliferating HUVECs. Furthermore, DIM down-regulated expression of cyclin-dependent kinase 2 and 6 (CDK2, CDK6), and upregulated expression of CDK inhibitor, p27Kip1, in HUVECs. We observed further in a complementary in vivo Matrigel plug angiogenesis assay that, compared with vehicle control, neovascularization was inhibited up to 76% following administration of 5 mg/kg DIM to female C57BL/6 mice. Finally, this dose of DIM also inhibited the growth of human MCF-7 cell tumor xenografts by up to 64% in female athymic (nu/nu) mice, compared to the vehicle control. This is the first study to show that DIM can strongly inhibit human breast tumor development in a xenograft model and to provide evidence for the antiangiogenic properties of this dietary indole.

Keywords: 3,3'-Diinolylmethane; Angiogenesis; Breast Tumor; Cell Cycle Arrest; HUVECs; Migration; Invasion; Tube Formation.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
K. W. Rahman, S. Ali, A. Aboukameel, S. H. Sarkar, Z. Wang, P. A. Philip, W. A. Sakr, and A. Raz
Inactivation of NF-{kappa}B by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells
Mol. Cancer Ther., October 1, 2007; 6(10): 2757 - 2765.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Kong, Y. Li, Z. Wang, S. Banerjee, and F. H. Sarkar
Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-{kappa}B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer
Cancer Res., April 1, 2007; 67(7): 3310 - 3319.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Gong, H. Sohn, L. Xue, G. L. Firestone, and L. F. Bjeldanes
3,3'-Diindolylmethane Is a Novel Mitochondrial H+-ATP Synthase Inhibitor that Can Induce p21Cip1/Waf1 Expression by Induction of Oxidative Stress in Human Breast Cancer Cells.
Cancer Res., May 1, 2006; 66(9): 4880 - 4887.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. W. Rahman, Y. Li, Z. Wang, S. H. Sarkar, and F. H. Sarkar
Gene Expression Profiling Revealed Survivin as a Target of 3,3'-Diindolylmethane-Induced Cell Growth Inhibition and Apoptosis in Breast Cancer Cells.
Cancer Res., May 1, 2006; 66(9): 4952 - 4960.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Gong, G. L. Firestone, and L. F. Bjeldanes
3,3'-Diindolylmethane Is a Novel Topoisomerase II{alpha} Catalytic Inhibitor That Induces S-Phase Retardation and Mitotic Delay in Human Hepatoma HepG2 Cells
Mol. Pharmacol., April 1, 2006; 69(4): 1320 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. A. Savino III, J. F. Evans, D. Rabinowitz, K. J. Auborn, and T. H. Carter
Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane.
Mol. Cancer Ther., March 1, 2006; 5(3): 556 - 563.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Chang, G. L. Firestone, and L. F. Bjeldanes
Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane
Carcinogenesis, March 1, 2006; 27(3): 541 - 550.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty and K. I. Block
Multifocal Angiostatic Therapy: An Update
Integr Cancer Ther, December 1, 2005; 4(4): 301 - 314.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.